Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Antiplatelet therapy

Ticagrelor reduces cardiac events in patients with PAD or diabetes

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bonaca, M. P. et al. Efficacy and safety of ticagrelor as long-term secondary prevention in patients with peripheral artery disease and prior myocardial infarction. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2016.03.524 (2016)

  2. Bhatt, D. L. et al. Reduction in ischemic events with ticagrelor in diabetic patients: from the PEGASUS-TIMI 54 trial. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2016.03.529 (2016)

  3. Franchi, F. et al. Pharmacodynamic effects of switching from prasugrel to ticagrelor: results of the prospective, randomized SWAP-3 study. JACC Cardiovasc. Interven. http://dx.doi.org/10.1016/j.jcin.2016.02.039 (2016)

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huynh, K. Ticagrelor reduces cardiac events in patients with PAD or diabetes. Nat Rev Cardiol 13, 310–311 (2016). https://doi.org/10.1038/nrcardio.2016.61

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2016.61

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing